SMARCA5 and acute myeloid leukemia: Inhibiting SMARCA5 to achieve suppression of AML growth may be thus a very efficient strategy as AML cells that are likely addicted to SMARCA5 in order to overcome various chromatin obstacles such as complex karyotype or also polyploidy often seen during progression of AML.